Immunovant (IMVT) Return on Invested Capital Growth (1y) (2020 - 2023)

Immunovant (IMVT) Return on Invested Capital Growth (1y) (2020 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 65.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -28.00
10 Immunovant 8.63 Bn 7.83 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 2,761.00
Sep 30, 2023 2,370.00
Jun 30, 2023 1,230.00
Jun 30, 2022 -1,017.00
Jun 30, 2021 64.00
Mar 31, 2021 39.00
Dec 31, 2020 15.00